View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
March 29, 2022

Amazon, THREAD sew alliance to bolster DCT platform

The collaboration is designed to reduce inefficiencies in real-time data capture and auto-populate data workflows.

By Reynald Castañeda

Amazon is diving further into decentralised clinical trials. 

Amazon Web Services (AWS) and decentralised clinical trial (DCT) technology and consultancy provider THREAD today announced they are collaborating to launch enhancements to the latter’s artificial intelligence-driven platform.

The newly added automation into THREAD’s DCT platform is designed to accelerate initiation of co-created and configured trials by reducing the start-up time to onboard users of the platform by as much as 30%. Also, users would be able to eliminate inefficiencies by more than 30% and reach as much as 25% cost savings when precompleting data. This reduces data capture and removing source data verification.

Further, users can precisely monitor and support investigation success by having richer data in real time, including real-time grades on trial performance. It also allows a secure review of participant data across the study, artificial intelligence support, and operational controls.

THREAD CEO John Reites said: “We are further scaling our DCT platform with next-level automation, AI/ML offerings, and optimised features focused to meet the evolving needs of our customers, research sites, and participants.”

THREAD CEO John Reites

AWS healthcare and life sciences general manager Dan Sheeran added: “The breadth and depth of AWS’s machine learning and cloud capabilities will help support THREAD teams as they work to automate processes, reduce inefficiencies, and monitor and support clinical trials.”

Amazon subsidiary AWS offers cloud computing platforms and application programming interface on a pay-as-you-go basis. Through the years, THREAD has been engaging with many players in the AI and clinical trials sector to bolster its capabilities.

Here at Clinical Trials Arena, we have been closely following the increasing uptake of DCTs, from pinpointing who and what is at the crest of the DCT wave, to the details such as challenges in direct-to-patient remote drug delivery and issues surrounding remote clinical trial monitoring.

Related Companies

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Clinical Trials Arena